Literature DB >> 9408974

Prenatal exposure to salicylates and gastroschisis: a case-control study.

M L Martínez-Frías1, E Rodríguez-Pinilla, L Prieto.   

Abstract

Gastroschisis, which is a defect in the abdominal wall, lateral to the umbilical cord, is considered to be a vascular problem, probably due to a disruption of the omphalomesenteric artery [Hoyme et al. (1981) J. Pediatr. 98:228-231]. Recently, Torfs et al. [(1996) Teratology 54:84-92] observed a significantly increased risk for aspirin and ibuprofen, two strong cyclooxygenase inhibitors. Here we present the results of a case-control study conducted by the Spanish Collaborative Study of Congenital Malformations (ECEMC) on the relationship between prenatal exposure to salicylates during the first trimester of pregnancy and gastroschisis. The results show an increased risk (OR = 3.47; P = 0.015) after controlling the possible effect of maternal age and maternal smoking during pregnancy.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9408974     DOI: 10.1002/(SICI)1096-9926(199710)56:4<241::AID-TERA2>3.0.CO;2-1

Source DB:  PubMed          Journal:  Teratology        ISSN: 0040-3709


  20 in total

Review 1.  Clinical risk factors for gastroschisis and omphalocele in humans: a review of the literature.

Authors:  Polina Frolov; Jasem Alali; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2010-08-31       Impact factor: 1.827

2.  The incidence of gastroschisis: is also increasing in Spain, particularly among babies of young mothers.

Authors:  Eva Bermejo; Jacobo Mendioroz; Lourdes Cuevas; María-Luisa Martínez-Frías
Journal:  BMJ       Date:  2006-02-18

3.  Non-steroidal anti-inflammatory drugs are not fully safe for fetus: comments on the article Treating common ear problems in pregnancy: what is safe? by Vlastarakos et al.

Authors:  Franciszek Burdan
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-02-07       Impact factor: 2.503

Review 4.  Teratogens inducing congenital abdominal wall defects in animal models.

Authors:  Dennis R Van Dorp; John M Malleis; Brian P Sullivan; Michael D Klein
Journal:  Pediatr Surg Int       Date:  2009-09-16       Impact factor: 1.827

Review 5.  Anticoagulant therapy and pregnancy.

Authors:  Aiko Makino; Mayumi Sugiura-Ogasawara
Journal:  Reprod Med Biol       Date:  2008-02-01

6.  Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects.

Authors:  Marlene Anderka; Allen A Mitchell; Carol Louik; Martha M Werler; Sonia Hernández-Diaz; Sonja A Rasmussen
Journal:  Birth Defects Res A Clin Mol Teratol       Date:  2011-11-19

Review 7.  Ongoing Pharmacological Management of Chronic Pain in Pregnancy.

Authors:  Bengt Källén; Margareta Reis
Journal:  Drugs       Date:  2016-06       Impact factor: 9.546

Review 8.  Postmarketing analysis of medicines: methodology and value of the spanish case-control study and surveillance system in preventing birth defects.

Authors:  María Luisa Martínez-Frías
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

9.  Is there epidemiologic evidence to support vascular disruption as a pathogenesis of gastroschisis?

Authors:  Martha M Werler; Allen A Mitchell; Cynthia A Moore; Margaret A Honein
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

Review 10.  Nonsteroidal anti-inflammatory agents in neonates.

Authors:  John L Morris; David A Rosen; Kathleen R Rosen
Journal:  Paediatr Drugs       Date:  2003       Impact factor: 3.022

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.